Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SeaStar Medical Holding ( (ICU) ) has issued an update.
On September 23, 2025, SeaStar Medical Holding Corporation’s Board of Directors approved salary increases for key executives and restored directors’ cash retainer fees to their original levels, effective October 1, 2025. These adjustments, following a prior 20% reduction in June 2025 to cut operating expenses, are expected to increase the company’s monthly operating expenses by approximately $50,000.
The most recent analyst rating on (ICU) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on SeaStar Medical Holding stock, see the ICU Stock Forecast page.
Spark’s Take on ICU Stock
According to Spark, TipRanks’ AI Analyst, ICU is a Underperform.
SeaStar Medical Holding faces significant financial challenges, with negative equity and reliance on external financing posing risks to its financial health. Technical indicators show bearish momentum, and valuation metrics highlight ongoing losses, contributing to a low overall stock score.
To see Spark’s full report on ICU stock, click here.
More about SeaStar Medical Holding
Average Trading Volume: 3,606,450
Technical Sentiment Signal: Sell
Current Market Cap: $16.81M
See more data about ICU stock on TipRanks’ Stock Analysis page.